Toralgen’s insulin-delivering nano-particle therapy accepted into the FDA’s Emerging Technology Program

diabetes
The TV ad campaign aired in Q4 2020, with Dexcom spending an estimated $7M on the campaign and generating over one billion impressions. Credit: Shutterstock.